The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $289.7 billion in 2022. China was the fastest growing country with a CAGR of 12.2% over the 2018-22 period.
- Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $213.2 billion in 2022. This was followed by Russia, India and Brazil with a value of $31.9, $24.2, and $20.4 billion, respectively.
- China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $355.2 billion in 2027, followed by Russia, India, Brazil with expected values of $40.0, $32.6 and $20.0 billion, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to Buy
- What was the size of the BRIC pharmaceuticals market by value in 2022?
- What will be the size of the BRIC pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the BRIC pharmaceuticals market?
Table of Contents
1 Introduction
2 BRIC Pharmaceuticals
3 Pharmaceuticals in Brazil
4 Macroeconomic Indicators
5 Pharmaceuticals in China
6 Macroeconomic Indicators
7 Pharmaceuticals in India
8 Macroeconomic Indicators
9 Pharmaceuticals in Russia
10 Macroeconomic Indicators
11 Company Profiles
12 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ache Laboratorios Farmaceuticos SA
- EMS Sigma Pharma
- Yangtze River Pharmaceutical Group
- Shanghai Pharmaceuticals Holding Co Ltd
- Yunnan Baiyao Group Co Ltd
- Guangzhou Pharmaceutical Holdings Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Ltd
- Dr. Reddy's Laboratories Limited
- Aurobindo Pharma Ltd
- Novartis AG
- Sanofi SA
- Bayer AG
- Les Laboratoires Servier